"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The United States will restrict routine Covid-19 boosters to people over 65 or those at higher risk of serious illness, while ...